PEGSTIM INJECTION 6 MG

Manufacturer
Zydus Cadila
Packaging
Injection
Composition
Pegfilgrastim 6MG
Availability
OTC
SKU
PROD-00980

Product Description

Pegstim 6 mg Injection contains Pegfilgrastim 6 mg, a long-acting granulocyte colony-stimulating factor used to reduce the risk of febrile neutropenia in patients receiving certain cancer chemotherapy treatments. It helps stimulate the bone marrow to produce more neutrophils, which are important white blood cells that help fight infections.

🔹 Key Uses
Pegfilgrastim may be used for:

Prevention of chemotherapy-induced neutropenia
Reduction of the risk of febrile neutropenia
Supporting white blood cell recovery after chemotherapy
Reducing the duration of severe neutropenia in eligible cancer patients
Supporting patients receiving chemotherapy regimens associated with a significant risk of neutropenia

🔹 Composition
Active ingredient: Pegfilgrastim 6 mg
Medicine class: Long-acting granulocyte colony-stimulating factor
Dosage form: Injectable solution

🔹 How It Works
Pegfilgrastim is a long-acting form of granulocyte colony-stimulating factor. It stimulates the bone marrow to produce and release neutrophils, helping the body recover white blood cell levels following chemotherapy and reducing the risk of serious infections.

🔹 Key Benefits

Helps increase neutrophil production
Reduces the duration of chemotherapy-induced neutropenia
Helps lower the risk of febrile neutropenia
Supports immune system recovery following chemotherapy
Long-acting formulation allows less frequent administration compared with short-acting filgrastim

🔹 Dosage and Administration
The dose and timing are determined by the treating oncologist according to the chemotherapy regimen and patient's medical condition.

The usual adult dose is 6 mg as a single injection per chemotherapy cycle, when appropriate.
It is generally administered subcutaneously.
It is usually given at least 24 hours after completion of cytotoxic chemotherapy.
It should not normally be administered within 24 hours before cytotoxic chemotherapy.
Do not self-administer unless specifically instructed and trained by your healthcare professional.

🔹 Possible Side Effects
Common side effects may include:

Bone pain
Muscle pain
Joint pain
Headache
Tiredness
Pain or redness at the injection site
Nausea

Serious side effects can include spleen enlargement or rupture, severe allergic reactions, acute respiratory distress, and inflammation of the aorta.

🔹 Precautions and Warnings

Use only under appropriate medical supervision.
Inform your doctor about any history of spleen disorders, blood disorders, or severe allergies.
Blood counts may be monitored during treatment.
Contact your doctor immediately for severe pain in the upper left abdomen or shoulder, difficulty breathing, swelling of the face or throat, or persistent fever.
Tell your doctor about all medicines and supplements you are taking because drug interactions may occur.
Pegfilgrastim is not a replacement for chemotherapy and should be used according to the prescribed cancer treatment protocol.

Additional Information

  • Category: category change
  • Manufacturer: Zydus Cadila
  • Packaging: Injection
  • Composition: Pegfilgrastim 6MG
  • Storage: Store in a cool, dry place away from direct sunlight
  • Shelf Life: As per manufacturer's guidelines
  • Prescription Status: Over-the-Counter (OTC)

How to Use

Important: Always follow your healthcare provider's instructions when using this medication.

  • Take this medicine as directed by your physician
  • Do not exceed the recommended dosage
  • Complete the full course of treatment even if symptoms improve
  • Store the medication properly as per storage instructions
  • Keep out of reach of children
  • Check expiry date before use

Note: This is general guidance. For specific instructions, please consult your healthcare provider or refer to the package insert.